333 related articles for article (PubMed ID: 24312590)
21. Modafinil alleviates levodopa-induced excessive nighttime sleepiness and restores monoaminergic systems in a nocturnal animal model of Parkinson's disease.
Ando R; Choudhury ME; Yamanishi Y; Kyaw WT; Kubo M; Kannou M; Nishikawa N; Tanaka J; Nomoto M; Nagai M
J Pharmacol Sci; 2018 Apr; 136(4):266-271. PubMed ID: 29661608
[TBL] [Abstract][Full Text] [Related]
22. Modafinil in the treatment of excessive daytime sleepiness in children.
Ivanenko A; Tauman R; Gozal D
Sleep Med; 2003 Nov; 4(6):579-82. PubMed ID: 14607353
[TBL] [Abstract][Full Text] [Related]
23. Placebo and modafinil effect on sleepiness in obstructive sleep apnea.
Bittencourt LR; Lucchesi LM; Rueda AD; Garbuio SA; Palombini LO; Guilleminault C; Tufik S
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):552-9. PubMed ID: 18053628
[TBL] [Abstract][Full Text] [Related]
24. A randomized trial of modafinil for the treatment of fatigue and excessive daytime sleepiness in individuals with chronic traumatic brain injury.
Jha A; Weintraub A; Allshouse A; Morey C; Cusick C; Kittelson J; Harrison-Felix C; Whiteneck G; Gerber D
J Head Trauma Rehabil; 2008; 23(1):52-63. PubMed ID: 18219235
[TBL] [Abstract][Full Text] [Related]
25. An open study of modafinil for the treatment of daytime somnolence and fatigue in primary biliary cirrhosis.
Jones DE; Newton JL
Aliment Pharmacol Ther; 2007 Feb; 25(4):471-6. PubMed ID: 17270003
[TBL] [Abstract][Full Text] [Related]
26. Modafinil improves functional outcomes in patients with residual excessive sleepiness associated with CPAP treatment.
Weaver TE; Chasens ER; Arora S
J Clin Sleep Med; 2009 Dec; 5(6):499-505. PubMed ID: 20465014
[TBL] [Abstract][Full Text] [Related]
27. Excessive daytime sleepiness in patients with Parkinson's disease.
Knie B; Mitra MT; Logishetty K; Chaudhuri KR
CNS Drugs; 2011 Mar; 25(3):203-12. PubMed ID: 21323392
[TBL] [Abstract][Full Text] [Related]
28. Modafinil for the Improvement of Patient Outcomes Following Traumatic Brain Injury.
Borghol A; Aucoin M; Onor I; Jamero D; Hawawini F
Innov Clin Neurosci; 2018 Apr; 15(3-4):17-23. PubMed ID: 29707422
[No Abstract] [Full Text] [Related]
29. Modafinil improves antipsychotic-induced parkinsonism but not excessive daytime sleepiness, psychiatric symptoms or cognition in schizophrenia and schizoaffective disorder: a randomized, double-blind, placebo-controlled study.
Lohr JB; Liu L; Caligiuri MP; Kash TP; May TA; Murphy JD; Ancoli-Israel S
Schizophr Res; 2013 Oct; 150(1):289-96. PubMed ID: 23938173
[TBL] [Abstract][Full Text] [Related]
30. Treatment of excessive daytime sleepiness in patients with Parkinson's disease with modafinil.
Nieves AV; Lang AE
Clin Neuropharmacol; 2002; 25(2):111-4. PubMed ID: 11981239
[TBL] [Abstract][Full Text] [Related]
31. Modafinil for excessive sleepiness associated with shift-work sleep disorder.
Czeisler CA; Walsh JK; Roth T; Hughes RJ; Wright KP; Kingsbury L; Arora S; Schwartz JR; Niebler GE; Dinges DF;
N Engl J Med; 2005 Aug; 353(5):476-86. PubMed ID: 16079371
[TBL] [Abstract][Full Text] [Related]
32. Effect of Wakefulness-Promoting Agents on Sleepiness in Patients with Sleep Apnea Treated with CPAP: A Meta-Analysis.
Sukhal S; Khalid M; Tulaimat A
J Clin Sleep Med; 2015 Oct; 11(10):1179-86. PubMed ID: 25979103
[TBL] [Abstract][Full Text] [Related]
33. Alertness and psychomotor performance effects of the histamine-3 inverse agonist MK-0249 in obstructive sleep apnea patients on continuous positive airway pressure therapy with excessive daytime sleepiness: a randomized adaptive crossover study.
Herring WJ; Liu K; Hutzelmann J; Snavely D; Snyder E; Ceesay P; Lines C; Michelson D; Roth T
Sleep Med; 2013 Oct; 14(10):955-63. PubMed ID: 23920422
[TBL] [Abstract][Full Text] [Related]
34. A prospective trial of modafinil as an adjunctive treatment of major depression.
DeBattista C; Lembke A; Solvason HB; Ghebremichael R; Poirier J
J Clin Psychopharmacol; 2004 Feb; 24(1):87-90. PubMed ID: 14709953
[TBL] [Abstract][Full Text] [Related]
35. Modafinil : A Review of its Pharmacology and Clinical Efficacy in the Management of Narcolepsy.
McClellan KJ; Spencer CM
CNS Drugs; 1998 Apr; 9(4):311-24. PubMed ID: 27521015
[TBL] [Abstract][Full Text] [Related]
36. The Use of Modafinil in the Intensive Care Unit.
Gajewski M; Weinhouse G
J Intensive Care Med; 2016 Feb; 31(2):142-5. PubMed ID: 25716122
[TBL] [Abstract][Full Text] [Related]
37. Modafinil for multiple sclerosis fatigue: does it work?
Littleton ET; Hobart JC; Palace J
Clin Neurol Neurosurg; 2010 Jan; 112(1):29-31. PubMed ID: 19837509
[TBL] [Abstract][Full Text] [Related]
38. Meta-analysis of the efficacy of modafinil versus placebo in the treatment of multiple sclerosis fatigue.
Shangyan H; Kuiqing L; Yumin X; Jie C; Weixiong L
Mult Scler Relat Disord; 2018 Jan; 19():85-89. PubMed ID: 29175676
[TBL] [Abstract][Full Text] [Related]
39. Managing excessive daytime sleepiness in adults.
Drug Ther Bull; 2004 Jul; 42(7):52-6. PubMed ID: 15270072
[TBL] [Abstract][Full Text] [Related]
40. Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial.
Dauvilliers Y; Bassetti C; Lammers GJ; Arnulf I; Mayer G; Rodenbeck A; Lehert P; Ding CL; Lecomte JM; Schwartz JC;
Lancet Neurol; 2013 Nov; 12(11):1068-75. PubMed ID: 24107292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
